LL-37 is a 37-residue amphiphilic histidine-derived antimicrobial peptide with broad antimicrobial activity. LL-37 helps protect the cornea from infections and modulates wound healing, while exhibiting antibacterial and anti-biofilm activity against a variety of Gram-positive and Gram-negative human pathogens, and has wound-healing effects on the host.
LL-37 is an antimicrobial peptide with angiogenic activity. It corresponds to amino acids 134-170 of the human cathelicidin antimicrobial protein hCAP18/LL-37 and is extracellularly released from hCAP18/LL-37 by proteolytic processing. hCAP18/LL-37 is an effector of the innate immune system and is expressed in leukocytes and epithelial cells where it is upregulated in association with inflammation and injury. An overexpression of hCAP18/LL-37 in a series of breast carcinomas could be demonstated